SCHEMBL18707692

SCHEMBL18707692

C[C@H](O)C[C@@](C)(N)c1nc(Br)ccc1F

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15990919 0.89 — —
SCHEMBL21442286 0.89 — —
SCHEMBL15991423 0.89 — —
SCHEMBL16079247 0.78 TRPV3 (0.31) —
SCHEMBL17742617 0.76 — —
SCHEMBL16166091 0.73 — —
SCHEMBL20606730 0.72 — —
SCHEMBL20606727 0.72 — —
SCHEMBL20606731 0.72 — —
SCHEMBL20606729 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611261-B2 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use AMGEN INC. (US) 2017-04-04 — — US disclosed
Send feedback